{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:AKT",
      "entity_text" : "Akt",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O00206",
      "entity_text" : "TLR4",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the current study, EPO downregulated the expression of TLR4, as well as its downstream inflammatory mediators, by activating the PI3K / Akt signaling pathway.",
  "reading_complete" : "2020-08-02T13:44:07Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:43:08Z",
  "trigger" : "activating",
  "evidence" : [ "TLR4, as well as its downstream inflammatory mediators, by activating the PI3K/Akt" ],
  "pmc_id" : "6089778",
  "score" : 0
}